| SC 13D/A | 2024-04-12 | SPRINGER TIMOTHY A | Cartesian Therapeutics, Inc. | 6,473,184 | 36.4% | EDGAR |
| SC 13D/A | 2024-04-10 | Singer Michael | Cartesian Therapeutics, Inc. | 769,744 | 4.3% | EDGAR |
| SC 13D/A | 2024-04-10 | Kalayoglu Murat | Cartesian Therapeutics, Inc. | 3,538,386 | 19.9% | EDGAR |
| SC 13D/A | 2024-03-28 | SPRINGER TIMOTHY A | Cartesian Therapeutics, Inc. | 194,189,313 | 27.9% | EDGAR |
| SC 13G/A | 2024-03-11 | FMR LLC | Cartesian Therapeutics, Inc. | 16,869,200 | 10.4% | EDGAR |
| SC 13G/A | 2024-02-14 | MANGROVE PARTNERS IM, LLC | Cartesian Therapeutics, Inc. | 4,127,258 | 2.6% | EDGAR |
| SC 13G/A | 2024-02-09 | Artal International S.C.A. | Cartesian Therapeutics, Inc. | 10,455,849 | 6.4% | EDGAR |
| SC 13G | 2024-02-09 | FMR LLC | Cartesian Therapeutics, Inc. | 13,256,374 | 8.2% | EDGAR |
| SC 13D | 2023-11-22 | Kalayoglu Murat | Cartesian Therapeutics, Inc. | 39,344,463 | 19.9% | EDGAR |
| SC 13D | 2023-11-22 | Singer Michael | Cartesian Therapeutics, Inc. | 26,060,927 | 13.9% | EDGAR |
| SC 13D/A | 2023-11-17 | SPRINGER TIMOTHY A | Cartesian Therapeutics, Inc. | 192,940,664 | 27.7% | EDGAR |
| SC 13D/A | 2023-09-25 | SPRINGER TIMOTHY A | SELECTA BIOSCIENCES INC | 44,356,586 | 28.9% | EDGAR |
| SC 13G | 2023-06-12 | Artal International S.C.A. | SELECTA BIOSCIENCES INC | 10,206,990 | 6.6% | EDGAR |
| SC 13G/A | 2023-02-14 | MANGROVE PARTNERS | SELECTA BIOSCIENCES INC | 9,387,677 | 6.0% | EDGAR |
| SC 13G | 2022-07-27 | MANGROVE PARTNERS | SELECTA BIOSCIENCES INC | 8,375,907 | 5.4% | EDGAR |
| SC 13G | 2022-05-24 | MANGROVE PARTNERS | SELECTA BIOSCIENCES INC | 8,000,907 | 5.1% | EDGAR |
| SC 13G | 2022-05-09 | BlackRock Inc. | SELECTA BIOSCIENCES INC | 6,806,285 | 4.5% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | SELECTA BIOSCIENCES INC | 875,859 | 1.4% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | SELECTA BIOSCIENCES INC | 6,951,882 | 6.0% | EDGAR |
| SC 13D/A | 2021-12-27 | SPRINGER TIMOTHY A | SELECTA BIOSCIENCES INC | 32,662,916 | 28.0% | EDGAR |